How has whole genome sequencing transformed the investigation of rare disease?
The way in which rare diseases are investigated has been opened up by whole genome sequencing. We look at its impact on both clinicians and patients
Polygenic scores show promise for improved prostate cancer detection
Three in ten men would have been spared an invasive prostate cancer-confirming biopsy if their own genomic data were considered, say Stanford University researchers
First results returned from NHS cancer blood test
Two in three patients with suspected cancer symptoms could receive an early diagnosis from a new blood test